Is COOLIEF* Cooled Radiofrequency the right option for me?
You may not be ready for surgery yet, and opioids have side effects that you might not want. That’s why COOLIEF* can bring non-surgical relief to those suffering from chronic pain, without the use of opioids.1-4
COOLIEF* is a minimally invasive treatment option targeting nerves that transmit pain signals and the first and only radiofrequency treatment FDA-cleared for the relief of osteoarthritis knee pain.5
The top 6 ways COOLIEF* cooled radiofrequency ablation can help with chronic pain
COOLIEF* has been proven to significantly improve long-term physical function and quality of life for OA knee patients for up to 12 months.
Because the procedure is minimally invasive, most patients can expect to feel pain relief within 1-2 weeks, returning to an enhanced quality of life much sooner than with surgery.
Since this outpatient treatment requires no general anesthesia, you can return home shortly after treatment.
ONE YEAR AFTER TREATMENT
2/3 of patients cut
reduction in patients experiencing symptoms of severe arthritis
How the COOLIEF* procedure works
Radiofrequency ablation deactivates the nerves responsible for sending pain signals to the brain.7 COOLIEF* is the only currently known radiofrequency pain management system using water-cooled technology to safely deactivate pain-transmitting sensory nerves, allowing a larger treatment area and greater chance at targeting pain-causing nerves.7 COOLIEF* is clinically proven to provide long-term pain relief, improve physical functionality, and reduce drug utilization.3,8
You may be eligible for COOLIEF* if:
Your pain has lasted for at least 3 months
You are not finding relief or want another option besides pills
You are not a candidate for or aren’t ready for surgery yet
There are COOLIEF*-trained specialists all across the country. Interested in an appointment?
I’m looking for a COOLIEF*-trained specialist for my pain near
- Malik A, Simopolous T, Elkersh M, et al. Percutaneous radiofrequency lesioning of sensory branches of the obturator and femoral nerves for the treatment of non-operable hip pain. Pain Physician. 2003;6:499-502.
- Kawaguchi M, Hashizume K, Iwata T, et al. Percutaneous radiofrequency lesioning of sensory branches of the obturator and femoral nerves for the treatment of hip joint pain. Reg Anesth Pain Med. 2001;26:576-581.
- Stelzer W, Aiglesberger M, Stelzer D, Stelzer V. Use of radiofrequency lateral branch neurotomy for the treatment of sacroiliac joint-mediated low back pain: a large case series. Pain Med. 2013;14:29-35.
- Rivera F, Mariconda C, Annaratone G. Percutaneous radiofrequency denervation in patients with contraindications for total hip arthoplasty. Orthopedics. 2012;35:e302-e305.
- Halyard Health Inc. sponsored study. A prospective, multi-center, randomized, clinical trial evaluating the safety and effectiveness of using COOLIEF Cooled Radiofrequency probe to create lesions of the genicular nerves and comparing corticosteroid steroid in the management of knee pain. Final results 03April2017. Study available upon request from Halyard.
- Bogduk N. Practice Guidelines for Spinal Diagnostic and Treatment Procedures. 1st ed. San Francisco, CA: International Spine Intervention Society; 2004.
- Kapural L, Nageeb F, Kapural M, et al. Cooled radiofrequency (RF) system for the treatment of chronic pain from sacroiliitis: the first case-series. Pain Pract. 2008;8:348-354.
- Ho KY, Hadi MA, Pasutharnchat K, Tan KH. Cooled radiofrequency denervation for treatment of sacroiliac joint pain: two-year results from 20 cases. J Pain Res. 2013;6:505-511.
- Choi WJ, Hwang SJ, Song JG, et al. Radiofrequency treatment relieves chronic knee osteoarthritis pain: a double-blind randomized controlled trial. Pain. 2011;152:481-487.
- Ikeuchi M, Ushida T, Izumi M, Tani T. Percutaneous radiofrequency treatment for refractory anteromedial pain of osteoarthritic knees. Pain Med. 2011;12:546-551.
- American Academy of Orthopaedic Surgeons. Information Statement 1045: Opioid Use, Misuse, and Abuse in Orthopaedic Practice. October 2015.